10x Genomics Inc (TXG) Live Share Price, Invest From India

10x Genomics Inc Stock Performance

as on March 4, 2026 at 6:11 am IST

Day's Low
Day's High
$21.41
Day's Price Range
$22.76
$22.81
6.14%
Downside
-0.22%
Upside
52 Week's Low
52 Week's High
$6.78
52-Week Price Range
$23.56
$22.81
70.28%
Downside
3.29%
Upside

10x Genomics Inc share price movements today

Previous Close: $23.14
Open: $22.00
Volume: 922.4K
Day's Low - High: $21.41 - $22.76
52 Week Low - High: $6.78 - $23.56

10x Genomics Inc Historical Returns

1 Month Return: + 20.02 %
3 Month Return: + 29.49 %
1 Year Return: + 134.92 %
3 Year Return: -54.63 %
5 Year Return: -86.64 %

10x Genomics Inc Stock Fundamentals & Key Indicators

Check 10x Genomics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.9B

EPS (TTM)

-0.1367

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-10.12

Industry PE ratio

8.1925

PEG Ratio

EBITDA

-64.1M

Revenue (TTM)

642.8M

Profit Margin

-6.77%

Return On Equity TTM

-5.78%

10x Genomics Inc Stock Valuation

Track how 10x Genomics Inc P/E has moved over time to understand its valuation trends.

10x Genomics Inc in the last 5 years

Overview
Trends

Lowest (-110.74x)

March 31, 2022

Today (-10.12x)

March 3, 2026

Industry (8.19x)

March 3, 2026

Highest (-12.96x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -10.12x

10x Genomics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 10x Genomics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
10x Genomics Inc	BUY	$2.9B	-86.64%	-10.12	-6.77%
Healthequity Inc	BUY	$6.6B	-0.32%	35.09	14.86%
Veeva Systems Inc.	BUY	$29.9B	-31.1%	35.48	27.93%
Tempus Ai	NA	$9.5B	NA	-25.89	-19.27%
Brightspring Health Services Inc.	BUY	$7.5B	NA	76.72	1.48%

Stock Returns calculator for 10x Genomics Inc Stock including INR - Dollar returns

The 10x Genomics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

10x Genomics Inc investment value today

Current value as on today

₹2,37,078

Returns

₹1,37,078

(+137.08%)

Returns from 10x Genomics Inc Stock

₹1,31,574 (+131.57%)

Dollar Returns*

₹5,505 (+5.5%)

Analyst Recommendation on 10x Genomics Inc Stock

Based on 20 analysts

BUY

75.00%

Buy

20.00%

Hold

5.00%

Sell

Based on 20 analysts, 75% of analysts recommend a 'BUY' rating for 10x Genomics Inc. Average target price of $19.79

10x Genomics Inc Share Price Target

Get share price movements and forecasts by analysts on 10x Genomics Inc.

What analysts predicted

-15.26%DOWNSIDE

Target Price

$19.79

Current Price

$22.81

Analyzed by

20 Analysts

Target

$19.79

10x Genomics Inc target price $19.79, a slight downside of -15.26% compared to current price of $22.81. According to 20 analysts rating.

10x Genomics Inc Stock’s Investor Sentiment and Interest

Search interest for 10x Genomics Inc Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 2, 2026 to March 4, 2026

Change:-33% versus previous 30 day period

10x Genomics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	153	183	141	153	151	165	154	172	149	166
Gross Profit	95	115	92	104	106	110	105	125	100	113
Operating Income	-94	-55	-61	-41	-41	-49	-39	30	-32	-19
EBITDA	-80	-34	-46	-26	-23	-37	-23	46	-15	-19
Interest Expense	0	0	0	0	0	0	-	0	0	-
Depreciation	11	11	11	10	10	10	9	9	12	12
Income Before Tax	-91	-46	-57	-37	-34	-48	-33	36	-28	-15
Income Tax Expense	1	2	2	0	1	0	0	2	0	1
Net Income	-92	-48	-59	-37	-35	-49	-34	34	-27	-16
Net Profit Margin	-60.52%	-26.61%	-42.52%	-24.75%	-23.58%	-29.71%	-22.18%	19.97%	-18.44%	-9.79%

10x Genomics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	71	146	245	298	490	516	618	610	642
Gross Profit	60	117	184	240	416	396	409	414	443
Operating Income	-18	-110	-29	-85	-52	-167	-265	-194	-110
EBITDA	-13	-106	-20	-513	-24	-128	-205	-133	-110
Interest Expense	0	2	3	1	0	0	0	0	-
Depreciation	4	3	7	19	28	33	43	43	43
Income Before Tax	-18	-112	-31	-534	-53	-161	-248	-177	-39
Income Tax Expense	0	0	0	8	4	4	6	4	3
Net Income	-18	-112	-31	-542	-58	-166	-255	-182	-43
Net Profit Margin	-26.39%	-76.88%	-12.71%	-181.61%	-11.87%	-32.15%	-41.23%	-29.90%	-6.77%

10x Genomics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-48	-59	-37	-35	-49	-34	34	-27	-16
Operating Cash Flow	25	-15	7	21	-6	34	17	43	40
Investing Cash Flow	13	10	11	-3	-51	-1	0	-8	-1
Financing Cash Flow	5	1	4	0	4	0	3	0	2
Change in Cash	44	-3	24	18	-54	32	20	34	41

10x Genomics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-112	-31	-542	-58	-166	-255	-182	-43
Operating Cash Flow	-76	34	-217	-21	-33	-15	6	136
Investing Cash Flow	-6	-42	-38	-106	-350	133	-32	-13
Financing Cash Flow	105	414	468	35	15	13	10	6
Change in Cash	22	406	212	-92	-368	131	-15	129

Global Institutional Holdings in 10x Genomics Inc

Funds	Holdings
State Street Corp	2%
AQR Capital Management LLC	2.13%
Jacobs Levy Equity Management, Inc.	2.07%
Jacobs Levy Equity Management, Inc.	1.93%
Wellington Management Company LLP	1.52%

See all

10x Genomics Inc News & Key Events

Insights on 10x Genomics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, TXG has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, TXG has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 149.00M → 166.03M (in $), with an average increase of 10.3% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, TXG stock has moved up by 21.2%
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -27.47M → -16.25M (in $), with an average increase of 69.0% per quarter

About 10x Genomics Inc

advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.

Organisation	10x Genomics Inc
Headquarters	6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260
Industry	Commercial Services
CEO	Dr. Serge Saxonov Ph.D.
E-voting on shares	Click here to vote

Key Management of 10x Genomics Inc

Name	Title
Mr. Jens Durruthy	Associate Director of Product Management
Dr. Serge Saxonov Ph.D.	Co-Founder, CEO & Director
Mr. Adam S. Taich	CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
Ms. Cassie Corneau	Manager of Investor Relations & Strategic Finance
Dr. Randy Wu	General Counsel and Secretary
Dr. Benjamin J. Hindson Ph.D.	Co-Founder, President, Chief Scientific Officer & Director
Mr. Jim Goodrich	Chief of Global Operations
Mr. Michael Schnall-Levin Ph.D.	Founding Scientist & CTO
Ms. Mennah Moustafa	Chief Commercial Officer

FAQs

What is 10x Genomics Inc share price today?

10x Genomics Inc share price today is $22.81 as on March 4, 2026 at 12:41 am IST. 10x Genomics Inc share today touched a day high of $22.76 and a low of $21.41.

What is the 52 week high and 52 week low for 10x Genomics Inc share?

10x Genomics Inc share touched a 52 week high of $23.56 on January 23, 2026 and a 52 week low of $6.78 on April 7, 2025. 10x Genomics Inc stock price today i.e. March 4, 2026 at 12:41 am IST is trending at $22.81,which is 3.18% down from its 52 week high and 236.43% up from its 52 week low.

What is 10x Genomics Inc's market capitalisation today?

10x Genomics Inc market capitalisation is $0.00T as on March 4, 2026 at 12:41 am IST.

How to invest in 10x Genomics Inc Stock (TXG) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for 10x Genomics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 10x Genomics Inc Shares that will get you 0.0658 shares as per 10x Genomics Inc share price of $22.81 per share as on March 4, 2026 at 12:41 am IST.

What is the minimum amount required to buy 10x Genomics Inc Stock (TXG) from India?

Indian investors can start investing in 10x Genomics Inc (TXG) shares with as little as ₹92.074 or $1 (as of March 4, 2026 at 12:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in 10x Genomics Inc stock (as per the Rupee-Dollar exchange rate as on March 4, 2026 at 12:41 am IST). Based on 10x Genomics Inc share’s latest price of $22.81 as on March 4, 2026 at 12:41 am IST, you will get 0.4384 shares of 10x Genomics Inc. Learn more about fractional shares .

What are the returns that 10x Genomics Inc has given to Indian investors in the last 5 years?

10x Genomics Inc stock has given -86.64% share price returns and 25.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?